GO:1903502 translation repressor complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903502 (translation repressor complex) is a cellular component defined as a protein complex capable of translation repressor activity.
• Core translation repressor complexes include 4EHP-containing complexes, CCR4-NOT deadenylase complexes, and TOB-containing complexes that inhibit mRNA translation [2,4,5,6].
• The mTORC1 signaling pathway regulates translation repressor complex assembly and activity in response to nutrient and growth factor cues.
• Translation repressor complexes are critical for immune defense, circadian rhythm, and developmental processes [1,4].
• Dysregulation of translation repressor complexes is linked to cancer, pulmonary fibrosis, and viral immune evasion [3,4,8].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of translation repressor complex components.
Description
The Gene Ontology (GO) term GO:1903502, translation repressor complex, defines a protein complex that is capable of translation repressor activity. This cellular component is essential for post-transcriptional gene regulation, allowing cells to rapidly and reversibly silence specific mRNAs in response to developmental, environmental, or immune signals [2,4]. Translation repressor complexes act at multiple steps of translation, including initiation, elongation, and mRNA deadenylation, thereby controlling protein output without altering transcript levels [2,5,6]. Understanding the composition, assembly, and regulation of translation repressor complexes is fundamental to dissecting gene expression programs in health and disease. Recent studies have identified key translation repressor complexes such as the 4EHP-mediated complex that represses cGAS translation to impede host immune responses against DNA viruses, and the TOB-CCR4-NOT complex that represses translation independent of deadenylation. These findings highlight the diverse molecular mechanisms and biological contexts in which translation repressor complexes operate. This article provides a comprehensive overview of GO:1903502, covering its definition, structure, molecular mechanisms, key genes, disease associations, and research methodologies, with a focus on CRISPR-based approaches for functional studies.
translation repressor complex At A Glance
| GO ID | GO:1903502 |
|---|---|
| GO term | translation repressor complex |
| Ontology | cellular_component |
| Synonym | None |
| Definition | A protein complex which is capable of translation repressor activity. |
| Major function | Repression of mRNA translation |
| Related processes | Post-transcriptional gene regulation, mRNA deadenylation, translation initiation control |
| Key components | 4EHP, CCR4-NOT subunits, TOB proteins, EZH2 (context-dependent) |
What Is GO:1903502?
GO:1903502 (translation repressor complex) is a cellular component defined by the Gene Ontology as a protein complex which is capable of translation repressor activity. In other words, it is a molecular machine composed of multiple proteins that assembles to inhibit the translation of messenger RNAs into proteins. This term encompasses any protein complex whose primary function is to repress translation, regardless of the specific mechanism (e.g., blocking initiation, promoting deadenylation, or interfering with ribosome function).
Why Is translation repressor complex Important in Cell Biology?
Translation repressor complexes are central to the precise control of gene expression, enabling cells to quickly adjust protein synthesis in response to stress, nutrients, and immune challenges. Their dysfunction contributes to a wide range of human diseases, including cancer, fibrosis, and viral infections. Moreover, translation repressor complexes are attractive therapeutic targets because they modulate the translation of specific mRNAs without affecting global transcription. Understanding their assembly and regulation is therefore critical for both basic biology and translational medicine.
• Regulate immune responses by repressing translation of immune sensors such as cGAS.
• Control circadian rhythm through translational repression of clock genes.
• Modulate cell growth and proliferation via mTORC1 signaling.
• Drive pulmonary fibrosis through FOXN3 phosphorylation and Smad signaling.
• Influence cancer progression by regulating oncogene translation.
• Coordinate developmental timing by repressing maternal mRNAs.
• Mediate viral immune evasion by blocking host defense translation.
• Provide targets for therapeutic intervention in fibrosis and cancer [3,8].
• Enable rapid post-transcriptional responses to environmental stress.
• Serve as models for studying mRNA-specific translational control [5,6].
Structure and Composition of translation repressor complex
4EHP-containing translation repressor complex
In simple terms: This complex uses a protein called 4EHP to block the start of translation.
The 4EHP-mediated translation repressor complex includes 4EHP (also known as EIF4E2) and associated factors that bind to the 5' cap of mRNAs, preventing assembly of the translation initiation machinery. This complex represses the translation of specific mRNAs, such as cGAS, thereby impeding host immune responses against DNA viruses. The assembly of this complex is regulated by cellular cues and can be targeted to specific transcripts through RNA-binding proteins.
CCR4-NOT deadenylase complex
In simple terms: This complex shortens the mRNA tail, leading to mRNA degradation and reduced translation.
The CCR4-NOT complex is a multi-subunit deadenylase that removes poly(A) tails from mRNAs, leading to translational repression and decay. It monitors translating ribosomes for codon optimality and can be recruited to specific mRNAs by adaptor proteins such as TOB [5,6]. The complex includes catalytic subunits CCR4 and CAF1, along with structural subunits NOT1, NOT2, NOT3, and others. Its activity is essential for diverse processes including cell cycle progression and stress responses.
TOB-containing translation repressor complex
In simple terms: TOB proteins help recruit the CCR4-NOT complex to mRNAs to repress translation without destroying the mRNA.
TOB proteins (TOB1 and TOB2) form a translation repressor complex with the CCR4-NOT deadenylase complex. This complex represses translation independently of deadenylation, suggesting a mechanism that may involve blocking translation initiation or elongation. TOB proteins interact with the CCR4-NOT complex through direct binding to NOT1, and this interaction is critical for their repressive function. The TOB-CCR4-NOT complex regulates genes involved in proliferation and differentiation.
EZH2-containing translation repressor complex
In simple terms: EZH2 can also repress translation by modifying ribosomal RNA, independent of its known role in chromatin.
EZH2, a histone methyltransferase, has a PRC2-independent function in regulating rRNA 2'-O methylation and IRES-dependent translation. EZH2 associates with components of the translation machinery to repress translation of specific mRNAs, including those with internal ribosome entry sites (IRES). This complex exemplifies the diversity of translation repressor complexes and their crosstalk with epigenetic regulators.
mTORC1-regulated translation repressor complexes
In simple terms: mTORC1 controls whether certain translation repressor complexes are active or inactive.
The mTORC1 signaling pathway regulates the assembly and activity of translation repressor complexes in response to nutrients and growth factors. For example, mTORC1 phosphorylates 4E-BP proteins, preventing them from inhibiting eIF4E and thus promoting translation. Conversely, when mTORC1 is inactive, 4E-BP proteins bind eIF4E and act as translation repressors. This regulatory axis integrates environmental signals with translational output.
Key Genes Involved in GO:1903502 translation repressor complex
The following genes encode core components and regulators of translation repressor complexes, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF4E2 (4EHP) | Cap-binding protein that represses translation initiation | Immune evasion, viral infection |
| CNOT1 | Scaffold subunit of CCR4-NOT complex | mRNA deadenylation, translation repression |
| CNOT2 | Subunit of CCR4-NOT complex | Complex assembly and stability |
| CNOT3 | Subunit of CCR4-NOT complex | Regulation of translation |
| CNOT4 | E3 ubiquitin ligase subunit of CCR4-NOT | Protein degradation and translation control |
| CNOT6 (CCR4a) | Catalytic deadenylase subunit | mRNA tail shortening |
| CNOT7 (CAF1a) | Catalytic deadenylase subunit | mRNA decay and translation repression |
| TOB1 | Adaptor that recruits CCR4-NOT to mRNAs | Translation repression independent of deadenylation |
| TOB2 | Paralog of TOB1, represses translation | Cell cycle regulation |
| EZH2 | PRC2-independent regulator of rRNA methylation and IRES translation | Cancer, translation control |
| FOXN3 | Transcription factor phosphorylated by NEK6, involved in Smad signaling | Pulmonary fibrosis |
| NEK6 | Kinase that phosphorylates FOXN3 | Fibrosis, cell cycle |
| EIF4EBP1 (4E-BP1) | mTORC1 substrate that inhibits eIF4E | Translation repression, cancer |
| EIF4EBP2 | Paralog of 4E-BP1 | Translation control |
| EIF4EBP3 | Paralog of 4E-BP1 | Translation control |
| DDX6 | RNA helicase involved in translation repression | mRNA storage and decay |
| PATL1 | Component of processing bodies, interacts with CCR4-NOT | mRNA repression |
How Is translation repressor complex Regulated?
Translation repressor complexes are regulated at multiple levels. The mTORC1 pathway controls the phosphorylation of 4E-BP proteins, which in turn determines whether they bind and inhibit eIF4E or release it to promote translation. Additionally, the assembly of CCR4-NOT complexes can be modulated by post-translational modifications and by interaction with adaptor proteins such as TOB. In the circadian clock, translation repressor complexes are regulated by clock proteins to maintain rhythmic protein expression. Furthermore, viral infection can alter the activity of translation repressor complexes to evade host immunity.
translation repressor complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EZH2 | Cancer, translation dysregulation | Knockout and overexpression in cancer cell lines |
| FOXN3 | Pulmonary fibrosis | Point mutation (phospho-dead) knock-in in lung fibroblasts |
| EIF4E2 (4EHP) | Viral immune evasion | Knockout in macrophages, viral infection models |
| TOB1 | Cell cycle regulation, cancer | Knockout and tagged knock-in in HeLa cells |
| CNOT1 | mRNA deadenylation, development | Knockout in embryonic stem cells |
Cancer
Dysregulation of translation repressor complexes contributes to cancer by altering the translation of oncogenes and tumor suppressors. For example, EZH2, a component of a translation repressor complex, is overexpressed in many cancers and promotes IRES-dependent translation of pro-survival factors. Targeting translation repressor complexes may offer therapeutic opportunities in cancers addicted to specific translational programs.
Pulmonary fibrosis
Phosphorylation of FOXN3 by NEK6 promotes pulmonary fibrosis through Smad signaling. FOXN3 is part of a translation repressor complex that regulates gene expression, and its dysregulation contributes to fibrotic remodeling. This highlights the role of translation repressor complexes in fibrotic diseases.
Viral infection and immune evasion
The 4EHP-mediated translation repressor complex represses cGAS translation, impeding the host immune response against DNA viruses. Viruses can exploit this complex to dampen innate immunity, suggesting that modulating translation repressor complexes could enhance antiviral defenses.
Circadian rhythm disorders
Translation repressor complexes are integral to the mammalian circadian clock, regulating the rhythmic translation of clock genes. Disruption of these complexes can lead to circadian rhythm disorders and associated metabolic syndromes.
From translation repressor complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of 4EHP enhance antiviral immunity? | EIF4E2 knockout in macrophages |
| How does FOXN3 phosphorylation affect fibrosis? | FOXN3 point mutation (S> A) knock-in in lung fibroblasts |
| What is the role of TOB1 in translation repression? | TOB1 knockout and tagged knock-in in HeLa cells |
| Does EZH2 regulate IRES-dependent translation? | EZH2 knockout and overexpression in cancer cells |
| How does mTORC1 control 4E-BP1 activity? | 4E-BP1 point mutation (phospho-mimetic) knock-in |
| What mRNAs are repressed by CCR4-NOT? | CNOT1 knockout with Ribo-seq |
How to Study the translation repressor complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Genome-wide translation efficiency | Identify mRNAs repressed by CNOT1 knockout |
| Polysome profiling | Ribosome loading on mRNAs | Assess translation repression by 4E-BP1 |
| RNA immunoprecipitation (RIP) | mRNA binding by proteins | Identify 4EHP target mRNAs |
| CLIP | Direct protein-RNA interactions | Map TOB1 binding sites |
| AP-MS | Protein-protein interactions | Define CCR4-NOT complex composition |
| Western blot | Protein expression levels | Validate knockout efficiency |
| Luciferase reporter assay | Translation of specific 5' UTRs | Test IRES-dependent translation |
Ribosome profiling (Ribo-seq)
Ribo-seq provides a genome-wide snapshot of translation by sequencing ribosome-protected mRNA fragments. It is used to identify mRNAs whose translation is repressed by specific translation repressor complexes, such as upon knockout of CNOT1 or TOB1 [5,6].
RNA immunoprecipitation (RIP) and CLIP
RIP and CLIP techniques identify mRNAs bound by translation repressor complex components, revealing direct targets. For example, CLIP of 4EHP can identify mRNAs whose translation it represses.
Polysome profiling
Polysome profiling separates mRNAs by the number of ribosomes bound, allowing assessment of translation efficiency. It is used to study the impact of translation repressor complexes on global and specific translation.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry (AP-MS) identifies the composition of translation repressor complexes and their dynamic interactions. This approach has been used to define the CCR4-NOT complex subunits.
How CRISPR Can Be Used to Study GO:1903502 translation repressor complex
Knockout
CRISPR knockout of genes encoding translation repressor complex components (e.g., EIF4E2, CNOT1, TOB1) enables loss-of-function studies to assess their role in translation repression and downstream phenotypes. For example, EIF4E2 knockout enhances cGAS translation and antiviral immunity.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes to dissect functional domains, such as phospho-dead or phospho-mimetic mutations in FOXN3 to study its regulation by NEK6 in fibrosis.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) into endogenous loci allows for endogenous protein purification and interaction studies, as demonstrated for TOB1 and CCR4-NOT subunits [5,6].
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can be used to increase levels of translation repressor complex components, enabling gain-of-function studies. Overexpression of EZH2 has been used to study its role in IRES-dependent translation.
How EDITGENE Supports translation repressor complex Research
Researchers studying translation repressor complex-related genes often need to determine whether a candidate gene is causally involved in translational repression and disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for translation repressor complex research.
Frequently Asked Questions About translation repressor complex
What is GO:1903502?
GO:1903502 is the Gene Ontology term for translation repressor complex, a protein complex capable of repressing mRNA translation.
What genes are involved in translation repressor complex?
Key genes include EIF4E2 (4EHP), CNOT1-7, TOB1, TOB2, EZH2, and EIF4EBP1-3 [2,4,5,6,8].
How is translation repressor complex regulated?
It is regulated by mTORC1 signaling, which controls 4E-BP phosphorylation, and by adaptor proteins like TOB that recruit CCR4-NOT [2,5].
What diseases are associated with translation repressor complex dysfunction?
Dysfunction is linked to cancer, pulmonary fibrosis, viral immune evasion, and circadian rhythm disorders [1,3,4,8].
What methods are used to study translation repressor complex?
Common methods include Ribo-seq, polysome profiling, RIP, CLIP, AP-MS, and CRISPR knockout models [2,4,5,6].
How does 4EHP repress translation?
4EHP binds the mRNA cap and blocks translation initiation, repressing specific mRNAs such as cGAS.
What is the role of CCR4-NOT in translation repression?
CCR4-NOT deadenylates mRNAs, leading to translational repression and decay, and monitors codon optimality.
Can CRISPR be used to study translation repressor complex?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of complex components [3,4,5,8].
What is the connection between translation repressor complex and cancer?
EZH2, a component of a translation repressor complex, is overexpressed in cancers and promotes IRES-dependent translation of pro-survival factors.
How does FOXN3 relate to translation repressor complex?
FOXN3 is part of a translation repressor complex, and its phosphorylation by NEK6 promotes pulmonary fibrosis through Smad signaling.
Conclusion
GO:1903502 (translation repressor complex) represents a critical node in post-transcriptional gene regulation, with diverse molecular compositions and essential roles in immunity, development, and disease. Understanding its structure, regulation, and function is key to developing therapeutic strategies for cancer, fibrosis, and viral infections. CRISPR-based models and advanced sequencing technologies continue to illuminate the complex biology of translation repression.
References
- 1. Liu Y et al.. 2026. Biochemical mechanism of the mammalian circadian clock.. FEBS Lett 600(6):716-731 PMID: 40854106
- 2. Thoreen CC et al.. 2012. A unifying model for mTORC1-mediated regulation of mRNA translation.. Nature 485(7396):109-13 PMID: 22552098
- 3. Yu J et al.. 2025. Phosphorylation of FOXN3 by NEK6 promotes pulmonary fibrosis through Smad signaling.. Nat Commun 16(1):1865 PMID: 39984467
- 4. Ladak RJ et al.. 2024. The 4EHP-mediated translational repression of cGAS impedes the host immune response against DNA viruses.. Proc Natl Acad Sci U S A 121(48):e2413018121 PMID: 39560640
- 5. Miyazaki K et al.. 2025. TOB Proteins Repress Translation via the CCR4-NOT Deadenylase Complex Independent of Deadenylation.. Genes Cells 30(5):e70042 PMID: 40755205
- 6. Buschauer R et al.. 2020. The Ccr4-Not complex monitors the translating ribosome for codon optimality.. Science 368(6488) PMID: 32299921
- 8. Yi Y et al.. 2021. A PRC2-independent function for EZH2 in regulating rRNA 2'-O methylation and IRES-dependent translation.. Nat Cell Biol 23(4):341-354 PMID: 33795875
